BayWa's Rescue Bid Unravels as US Policy Shift Exposes €2.7 Billion Hole

BayWa's restructuring collapses after US subsidy repeal, creating a €2.7bn funding gap. Its energy unit's value plummets, forcing asset sales and reliance on bank approval for survival.

A political decision in Washington has sent shockwaves through the restructuring plans of German agricultural conglomerate BayWa, exposing a massive funding shortfall and pushing its key energy subsidiary into crisis. The failure of a core asset sale has left the company scrambling to secure its future, with its fate now resting in the hands of its bankers.

The cornerstone of BayWa's recovery strategy was the planned sale of a 51% stake in its renewable energy unit, BayWa r.e., which was expected to raise up to €1.7 billion. That plan collapsed after the United States repealed subsidies for renewable energy projects at the start of 2025 under the "One Big Beautiful Bill Act." Without state support, the value of US projects plummeted, making a sale at the anticipated price impossible. This policy shift has fundamentally altered the unit's earnings outlook, forcing BayWa to slash its EBITDA forecast for the division. The company now expects just €150 million in 2030, a 35% drop from the original €230 million target for 2028.

The operational turmoil has triggered a governance crisis. At BayWa r.e., three representatives from minority shareholder Energy Infrastructure Partners (EIP) have resigned from the supervisory board, reportedly over a dispute concerning control functions. This exodus strikes at a critical moment, as the parent company's survival is directly tied to the economic recovery of this very division.

With the flagship sale off the table, BayWa's entire restructuring timeline has been extended from 2028 to 2030. The scale of the challenge is stark: of the €4 billion in divestments needed, only €1.3 billion has been secured, leaving a €2.7 billion financing gap. The recent sale of its grain trading subsidiary Cefetra will reduce group bank debt by over €600 million and provides some near-term cash, with a final €45 million payment due by the end of April alongside roughly €62 million from shareholder loan repayments. Yet this is insufficient.

Management is now forced to consider selling profitable assets. The focus has turned to T&G Global, the New Zealand-based fruit trading business in which BayWa holds a nearly 74% stake. Although T&G returned to profitability in 2024 with net earnings of $16 million on revenue of $1.3 billion, a sale led by Goldman Sachs since March 2026 is expected to yield only about €300 million. The process is further complicated by a minority shareholder from Hong Kong.

The entire operational foundation of the group now hinges on securing formal approval from its creditor banks, led by DZ Bank and HVB. Their consent is required to extend a standstill agreement until autumn 2026; without it, the prolonged restructuring plan loses its legal footing. The depth of creditor concern is already visible: in the 2024 accounts, 60% of a €220 million bond from Bavarian cooperative banks was written down.

Investors are navigating a profound information vacuum. The publication of the 2025 group financial statements is delayed until likely the fourth quarter of 2026. Compounding the uncertainty, the management board has withdrawn its guidance for the current year and lowered its adjusted EBITDA target for 2027 to approximately €140 million. The long-term plan aims to concentrate the group on four core business areas by the end of 2028, cutting around 1,300 jobs and reducing revenue to about €10 billion.

The market has rendered its verdict on the escalating risks. BayWa's share price has fallen nearly 20% since the start of the year, trading roughly 21% below its 200-day moving average. Two events will now dictate the company's trajectory: a successful agreement with its banks and the delivery of audited financials, both unlikely before the final quarter of 2026.